Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity, Vaccine”

4,742 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,742 results

Early research (Phase 1)Ended earlyNCT03956056
What this trial is testing

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Not applicableNot Yet RecruitingNCT07433881
What this trial is testing

Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 360
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Post-approval studies (Phase 4)Active Not RecruitingNCT07154537
What this trial is testing

Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
National Taiwan University Hospital 101
Testing effectiveness (Phase 2)Study completedNCT01926028
What this trial is testing

Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis

Who this might be right for
Vulvovaginal Candidiasis
NovaDigm Therapeutics, Inc. 188
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT01155037
What this trial is testing

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

Who this might be right for
HIV Infection
Oswaldo Cruz Foundation 450
Early research (Phase 1)Study completedNCT03827395
What this trial is testing

Safety Study of Hepatitis E Vaccine (HEV239)

Who this might be right for
Hepatitis EImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT02892812
What this trial is testing

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Who this might be right for
Pneumococcal Infections
LG Life Sciences 63
Post-approval studies (Phase 4)Study completedNCT00289757
What this trial is testing

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Who this might be right for
Hepatitis A
GlaxoSmithKline 78
Large-scale testing (Phase 3)WithdrawnNCT06567457
What this trial is testing

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty
Early research (Phase 1)Study completedNCT01741012
What this trial is testing

Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
Wayne State University 37
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Large-scale testing (Phase 3)Study completedNCT00973700
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

Who this might be right for
Novel 2009 Influenza H1N1
Novartis Vaccines 784
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Testing effectiveness (Phase 2)Study completedNCT03313037
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Who this might be right for
Pneumococcal Infections
Pfizer 444
Early research (Phase 1)Study completedNCT01317745
What this trial is testing

H5N1 Mix and Match With MF59

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 270
Testing effectiveness (Phase 2)Study completedNCT04681833
What this trial is testing

Safety and Efficacy of BARS13 in the Elderly

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 125
Load More Results